ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)
Johanna A van der Zande(Erasmus MC), Magdalena Lipczyńska(Institute of Cardiology), Edit Nagy(Brigham and Women's Hospital), Arie Franx(Erasmus MC - Sophia Children’s Hospital), Edison Muñoz-Ortiz(Universidad de Antioquia), Tobias Rutz(University of Lausanne), Katja Prokšelj(Ljubljana University Medical Centre), Karishma P. Ramlakhan(Erasmus MC), Amalia Baroutidou(Aristotle University of Thessaloniki), Mark R. Johnson(Imperial College London), Roger Hall(University of East Anglia)
Cited by 9
Related Papers
Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves
|American Journal Of Pathology|2017|68
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
|Cardiovascular Diabetology|2021|48
Women leaders in Cardiology. Contemporary profile of the WHO European region
|European Heart Journal Open|2021|22
Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
|Journal of Clinical Medicine|2022|22